Polymerizable superoxide dismutase mimetic protects cells encapsulated in poly(ethylene glycol) hydrogels from reactive oxygen species-mediated damage

Journal of Biomedical Materials Research - Part A

Volumn 99 A, Issue 1, 2011, Pages 29-37

  Hume, Patrick S ^a   Anseth, Kristi S ^a  

^a UCB 450   (United States)

Author keywords

cell; hydrogel; reactive oxygen species; superoxide; superoxide dismutase

Indexed keywords

BARRIER MATERIAL; CELL ENCAPSULATIONS; DIACRYLATES; ENCAPSULATED CELL; METABOLIC ACTIVITY; METALLOPORPHYRINS; OXIDATIVE DAMAGE; PEG HYDROGEL; POLY(ETHYLENE GLYCOL) HYDROGEL; PYRIDYL; REACTIVE OXYGEN; REACTIVE OXYGEN SPECIES; SIZE EXCLUSION; SUPER OXIDE DISMUTASE; SUPEROXIDES; TETRAKIS; UNTREATED CONTROL;

CELLS; ETHYLENE; FUNCTIONAL POLYMERS; GLYCOLS; MANGANESE; METABOLISM; OXYGEN; POLYETHYLENE GLYCOLS; PORPHYRINS; TISSUE;

HYDROGELS;

ACRYLIC ACID DERIVATIVE; BIOMIMETIC MATERIAL; MACROGOL; MANGANESE; METALLOPORPHYRIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAKIS[1 (3 ACRYLOXYPROPYL) 4 PYRIDYL]PORPHYRIN MANGANESE POLYETHYLENE GLYCOL CONJUGATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL ENCAPSULATION; CELL PROTECTION; CHEMICAL STRUCTURE; COVALENT BOND; HYDROGEL; IMMUNOSTIMULATION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; POLYMERIZATION;

ANIMALS; BIOMIMETIC MATERIALS; CELLS, CULTURED; HYDROGELS; METALLOPORPHYRINS; MICE; POLYETHYLENE GLYCOLS; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIME FACTORS;

EID: 80051874184     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33160     Document Type: Article

References (58)

1. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S,. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-719. (Pubitemid 32204988)
2. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L,. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994; 331: 889-895. (Pubitemid 24299869)
3. Pavlakis M, Khwaja K,. Pancreas and islet cell transplantation in diabetes. Curr Opin Endocrinol Diabetes Obes 2007; 14: 146-150. (Pubitemid 46363296)
4. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV,. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238. (Pubitemid 30490390)
5. White SA, Shaw JA, Sutherland DE,. Pancreas transplantation. Lancet. 2009; 373: 1808-1817.
6. Bertuzzi F, Ricordi C,. Beta-cell replacement in immunosuppressed recipients: Old and new clinical indications. Acta Diabetol 2007; 44: 171-176. (Pubitemid 350132261)
7. Wilson JT, Chaikof EL,. Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Deliv Rev 2008; 60: 124-145. (Pubitemid 350245691)
8. Nyberg SL, Yagi T, Matsushita T, Hardin J, Grande JP, Gibson LE, Platt JL,. Membrane barrier of a porcine hepatocyte bioartificial liver. Liver Transpl 2003; 9: 298-305. (Pubitemid 36322333)
9. Shi XL, Zhang Y, Han B, Gu JY, Chu XH, Xiao JQ, Ren HZ, Tan JJ, Ding YT,. Effects of membrane molecular weight cutoff on performance of a novel bioartificial liver. Artif Organs 2011; 35: E40-E46.
10. Emerich DF, Winn SR,. Immunoisolation cell therapy for CNS diseases. Crit Rev Ther Drug Carrier Syst 2001; 18: 265-298. (Pubitemid 32587885)
11. Lee MK, Bae YH,. Cell transplantation for endocrine disorders. Adv Drug Delivery Rev 2000; 42: 103-120. (Pubitemid 30609637)
12. de Vos P, Hamel AF, Tatarkiewicz K,. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002; 45: 159-173. (Pubitemid 34208378)
13. Cui H, Tucker-Burden C, Cauffiel SM, Barry AK, Iwakoshi NN, Weber CJ, Safley SA,. Long-term metabolic control of autoimmune diabetes in spontaneously diabetic nonobese diabetic mice by nonvascularized microencapsulated adult porcine islets. Transplantation 2009; 88: 160-169.
14. Cruise GM, Hegre OD, Lamberti FV, Hager SR, Hill R, Scharp DS, Hubbell JA,. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant 1999; 8: 293-306. (Pubitemid 29350225)
15. Weber LM, Hayda KN, Anseth KS,. Cell-matrix interactions improve beta-cell survival and insulin secretion in three-dimensional culture. Tissue Eng Part A 2008; 14: 1959-1968.
16. Weber LM, Anseth KS,. Hydrogel encapsulation environments functionalized with extracellular matrix interactions increase islet insulin secretion. Matrix Biol 2008; 27: 667-673.
17. Lin CC, Anseth KS,. Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-Cells. Biomacromolecules 2009; 10: 2460-2467.
18. Jang JY, Lee DY, Park SJ, Byun Y,. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Biomaterials 2004; 25: 3663-3669. (Pubitemid 38327055)
19. de Vos P, Marchetti P,. Encapsulation of pancreatic islets for transplantation in diabetes: The untouchable islets. Trends Mol Med 2002; 8: 363-366. (Pubitemid 34826718)
20. Mohseni Salehi Monfared SS, Larijani B, Abdollahi M,. Islet transplantation and antioxidant management: a comprehensive review. World J Gastroenterol 2009; 15: 1153-1161.
21. Hadjivassiliou V, Green MH, James RF, Swift SM, Clayton HA, Green IC,. Insulin secretion. DNA damage, and apoptosis in human and rat islets of Langerhans following exposure to nitric oxide, peroxynitrite, and cytokines. Nitric Oxide 1998; 2: 429-441. (Pubitemid 29231176)
22. Di Matteo MA, Loweth AC, Thomas S, Mabley JG, Morgan NG, Thorpe JR, Green IC,. Superoxide, nitric oxide, peroxynitrite and cytokine combinations all cause functional impairment and morphological changes in rat islets of Langerhans and insulin secreting cell lines, but dictate cell death by different mechanisms. Apoptosis 1997; 2: 164-177. (Pubitemid 127505722)
23. Delaney CA, Tyrberg B, Bouwens L, Vaghef H, Hellman B, Eizirik DL,. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett 1996; 394: 300-306. (Pubitemid 26341462)
24. Lin CC, Metters AT, Anseth KS,. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha. Biomaterials 2009; 30: 4907-4914.
25. Sun LT, Bencherif SA, Gilbert TW, Farkas AM, Lotze MT, Washburn NR,. Biological activities of cytokine-neutralizing hyaluronic acid-antibody conjugates. Wound Repair Regen 2010; 18: 302-310.
26. Muscoli C, Cuzzocrea S, Riley DP, Zweier JL, Thiemermann C, Wang ZQ, Salvemini D,. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br J Pharmacol 2003; 140: 445-460. (Pubitemid 37330489)
27. Lenzen S, Drinkgern J, Tiedge M,. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996; 20: 463-466. (Pubitemid 26077870)
28. Grankvist K, Marklund S, Taljedal IB,. Superoxide dismutase is a prophylactic against alloxan diabetes. Nature 1981; 294: 158-160. (Pubitemid 12217972)
29. Piganelli JD, Flores SC, Cruz C, Koepp J, Batinic-Haberle I, Crapo J, Day B, Kachadourian R, Young R, Bradley B, Haskins K,. A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone. Diabetes 2002; 51: 347-355. (Pubitemid 34764789)
30. Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Buckley B, Mirochnitchenko O,. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J Biol Chem 2005; 280: 22530-22539. (Pubitemid 40827911)
31. Pedulla M, d'Aquino R, Desiderio V, de Francesco F, Puca A, Papaccio G,. MnSOD mimic compounds can counteract mechanical stress and islet beta cell apoptosis, although at appropriate concentration ranges. J Cell Physiol 2007; 212: 432-438. (Pubitemid 47025633)
32. Nomikos IN, Wang Y, Lafferty KJ,. Involvement of O2 radicals in 'autoimmune' diabetes. Immunol Cell Biol 1989; 67 (Pt 1): 85-87.
33. Salvemini D, Riley DP, Cuzzocrea S,. SOD mimetics are coming of age. Nat Rev Drug Discov 2002; 1: 367-374. (Pubitemid 37361466)
34. Pasternack RF, Banth A, Pasternack JM, Johnson CS,. Catalysis of the disproportionation of superoxide by metalloporphyrins. III. J Inorg Biochem 1981; 15: 261-267.
35. Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X, Pugazhenthi S, Reusch J, Kench J,. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 2003; 1005: 43-54. (Pubitemid 38507733)
36. Benov L, Batinic-Haberle I,. A manganese porphyrin suppresses oxidative stress and extends the life span of streptozotocin-diabetic rats. Free Radic Res 2005; 39: 81-88. (Pubitemid 40309473)
37. Szabo C, Day BJ, Salzman AL,. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger. FEBS Lett 1996; 381: 82-86.
38. Day BJ, Fridovich I, Crapo JD,. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch Biochem Biophys 1997; 347: 256-262. (Pubitemid 27492797)
39. Nakaoka R, Tabata Y, Yamaoka T, Ikada Y,. Prolongation of the serum half-life period of superoxide dismutase by poly(ethylene glycol) modification. J Controlled Release 1997; 46: 253-261. (Pubitemid 27132849)
40. Kojima Y, Akaike T, Sato K, Maeda H, Hirano T,. Polymer conjugation to Cu,Zn-SOD and suppression of hydroxyl radical generation on exposure to H2O2: Improved stability of SOD in vitro and in vivo. J Bioact Compat Polym 1996; 11: 169-190. (Pubitemid 26297485)
41. Li Z, Wang F, Roy S, Sen CK, Guan J,. Injectable, highly flexible, and thermosensitive hydrogels capable of delivering superoxide dismutase. Biomacromolecules 2009; 10: 3306-3316.
42. Chiumiento A, Dominguez A, Lamponi S, Villalonga R, Barbucci R,. Anti-inflammatory properties of superoxide dismutase modified with carboxymetil-cellulose polymer and hydrogel. J Mater Sci Mater Med 2006; 17: 427-435. (Pubitemid 43827972)
43. Chiumiento A, Lamponi S, Barbucci R, Dominguez A, Perez Y, Villalonga R,. Immobilizing Cu,Zn-superoxide dismutase in hydrogels of carboxymethylcellulose improves its stability and wound healing properties. Biochemistry (Mosc) 2006; 71: 1324-1328. (Pubitemid 44957913)
44. Cheung CY, McCartney SJ, Anseth KS,. Synthesis of polymerizable superoxide dismutase mimetics to reduce reactive oxygen species damage in transplanted biomedical devices. Adv Functional Mater 2008; 18: 3119-3126.
45. McCord JM, Fridovich I,. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055.
46. Cohen HJ, Chovaniec ME,. Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system. J Clin Invest 1978; 61: 1081-1087. (Pubitemid 8321085)
47. Choi SY, Ha H, Kim KT,. Capsaicin inhibits platelet-activating factor-induced cytosolic Ca2+ rise and superoxide production. J Immunol 2000; 165: 3992-3998. (Pubitemid 32057310)
48. Cruise GM, Scharp DS, Hubbell JA,. Characterization of permeability and network structure of interfacially photopolymerized poly (ethylene glycol) diacrylate hydrogels. Biomaterials 1998; 19: 1287-1294. (Pubitemid 28391475)
49. Lin CC, Boyer PD, Aimetti AA, Anseth KS,. Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation. J Controlled Release 2010; 142: 384-391.
50. Lin CC, Anseth KS,. Cell-cell communication mimicry with PEG hydrogels for enhancing Beta-cell function. Proc Natl Acad Sci U S A. Forthcoming.
51. Weber LM, Hayda KN, Haskins K, Anseth KS,. The effects of cell-matrix interactions on encapsulated beta-cell function within hydrogels functionalized with matrix-derived adhesive peptides. Biomaterials 2007; 28: 3004-3011. (Pubitemid 46560870)
52. Hume PS, Bowman CN, Anseth, KS,. Functionalized PEG hydrogels through reactive dip-coating for the formation of immunoactive barriers. Biomaterials. Forthcoming.
53. Gabler WL, Creamer HR, Bullock WW,. Modulation of the kinetics of induced neutrophil superoxide generation by fluoride. J Dent Res 1986; 65: 1159-1165. (Pubitemid 17173684)
54. Su J, Hu BH, Lowe WL Jr, Kaufman DB, Messersmith PB,. Anti-inflammatory peptide-functionalized hydrogels for insulin-secreting cell encapsulation. Biomaterials 2010; 31: 308-314.
55. Kavdia M, Lewis RS,. Free radical profiles in an encapsulated pancreatic cell matrix model. Ann Biomed Eng 2002; 30: 721-730. (Pubitemid 34783439)
56. Uchiyama T, Kiritoshi Y, Watanabe J, Ishihara K,. Degradation of phospholipid polymer hydrogel by hydrogen peroxide aiming at insulin release device. Biomaterials 2003; 24: 5183-5190. (Pubitemid 37272282)
57. Cheung CY, Anseth KS,. Synthesis of immunoisolation barriers that provide localized immunosuppression for encapsulated pancreatic islets. Bioconjugate Chem 2006; 17: 1036-1042. (Pubitemid 44162624)
58. Hume PS, Anseth KS,. Inducing local T cell apoptosis with anti-Fas-functionalized polymeric coatings fabricated via surface-initiated photopolymerizations. Biomaterials 2010; 31: 3166-3174.